Physician

CRAACO is the only program to address how to connect clinical research to clinical care and what it takes to integrate both for better access.  The conference is designed to bring together all of the stakeholders from Pharma companies, Biotechs and CROs, as well as hospital and healthcare systems and physician groups to discuss how this has been done, some of the challenges, and explore the strategies, partnerships, and tools to achieve it.

The leading clinical trial supply conference in East Asia with a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials. This event focuses on the regional pharmaceutical business in Asia, highlighting the industry’s current difficulties as well as its exciting innovations and growth prospects.

This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining our OCT, CTS and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about latest developments.

The premier destination to learn the latest in the field of thrombosis and hemostasis while you form international connections that benefit the field and your career. Thousands of the world’s leading experts on thrombosis, hemostasis and vascular biology come together to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.

Through an extensive lineup of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities, the Congress promotes important scientific discourse and advancement.

SOHO is the premier meeting that focuses specifically on new advances and practical clinical applications in the field of hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.

The SOHO 2025 meeting theme will be “Unleashing AI, Genomics, Targets, and Immune Engineering” as it relates to the field of hematologic oncology. Topics will be covered in the latest advances in the pathophysiology and therapy of: leukemias, lymphomas, myeloma, myelodysplastic neoplasms, myeloproliferative neoplasms, related malignancies and exciting developments in cellular therapy. 

More than 1,200 pediatric hematology/oncology professionals from around the world attend the ASPHO Conference each year. The leading meeting for the field, the ASPHO Conference allows attendees to receive high-quality educational content, network with their colleagues, and discover innovative advancements in pediatric hematology/oncology.

The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting showcases cutting-edge cancer science and medicine.

The West Virginia Oncology Society (WVOS) is a powerful community of oncologists, nurse practitioners, physician assistants, and other allied health professionals who provide a voice for multidisciplinary cancer care teams and the patients they serve.

Founded in 2008, WVOS is the largest oncology professional organization in the state. Members rely on us to provide innovative resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve—both locally and on a national level.

Society of Utah Medical Oncologists

Managing lung cancer has become increasingly complicated – reflecting the transformative benefits we see with immunotherapy and targeted therapy. Learn the best way to deliver these drugs from the very investigators leading the research. This two-day CME-event will review the latest advances in lung cancer focused on what a medical oncologist needs to know to provide state-of-the-art care today. Featured speaker and TxSCO President Debra Patt, MD, PhD, MBA, FASCO, will share the latest on healthcare policy, while expert faculty will cover the basics (”What is NGS?”) and the advanced (“How can we predict and prevent acquired resistance?”) making this conference appropriate for all levels of training and experience.